Notably, TP53/RB1 co‐alteration occurs in ~36% of pulmonary large cell neuroendocrine carcinoma (LCNEC) and ~35% of extra‐thoracic LCNEC patients [9]. Here, RB1 is linked to large cell neuroendocrine carcinoma.